Apollo Hospitals Enterprise Ltd

(APOLLOHOSP)

Apollo Hospitals Reports Strong Q1FY25 Performance - 12 Sep, 2024

Apollo Hospitals Enterprise Limited reported a 15% YoY revenue growth in Q1FY25, reaching Rs. 5,086 Crores, with profits increasing from Rs. 173 Crores to Rs. 316 Crores. The stock traded at Rs. 6,906.5, up 0.04%.

Apollo Hospitals Expands Stake and Launches Insurance Subsidiary - 05 Sep, 2024

Apollo Healthco has incorporated Apollo 24/7 Insurance Services to operate as corporate agents for life insurance. The company also increased its stake in AHL by 0.09% through a Rs 399.99 crore subscription. Q1 FY25 net profit surged 83.9% to Rs 305.2 crore, with a 15.12% YoY revenue increase to Rs 5,085.6 crore. The stock rose 0.71% to Rs 6,978.30.

Apollo Hospitals Launches Research Academy for Innovation - 04 Sep, 2024

Apollo Hospitals has launched the Apollo Research Academy (ARA) to enhance healthcare research and innovation. The initiative aims to foster collaboration and build partnerships in research, focusing on key areas such as sponsored research and data sciences, under the leadership of Professor Ravi P Mahajan.

Apollo Hospitals Sees Growth in Medical Tourism - 02 Sep, 2024

Apollo Hospitals is expanding its international outreach as India's medical tourism sector rebounds post-pandemic. The company aims to become a preferred destination for global patients.

Avesthagen and Apollo AyurVAID Form Strategic Partnership - 28 Aug, 2024

Avesthagen Ltd has partnered with Apollo AyurVAID to create scientifically validated medical foods and dietary supplements, aiming to set new industry standards for quality and safety.

Nomura Downgrades Apollo Hospitals Amid Profitability Concerns - 26 Aug, 2024

Apollo Hospitals' stock faces challenges as Nomura downgrades it to neutral, raising the target price while highlighting gradual profitability growth and expansion impacts on EBITDA margins.

Apollo Hospitals Reports Strong Revenue Growth - 25 Aug, 2024

Apollo Hospitals Enterprise reported a 15% year-on-year increase in revenue for Q1FY25, reaching Rs 5,086 crore. Key specialties contribute significantly to inpatient revenues.

ICICI Securities Maintains HOLD on Apollo Hospitals - 22 Aug, 2024

ICICI Securities retains a HOLD rating on Apollo Hospitals, raising the target price to Rs 6,215. The company aims for improved hospital margins and occupancy, despite delays in greenfield bed additions impacting EBITDA margins in FY26E.

Apollo Hospitals Gains CCI Approval and Positive Outlook - 21 Aug, 2024

The CCI has approved Advent's acquisition in Apollo Healthco, while Motilal Oswal raised the target price to Rs 7940, highlighting strong performance and cost reductions.

Apollo Hospitals Reports Strong EBITDA Growth - 20 Aug, 2024

Apollo Hospitals Enterprise Ltd reported a consolidated EBITDA of Rs 6.75 billion, up 33% YoY. The company maintains a BUY rating with a target price of Rs 7,150/share, supported by positive developments in its business strategy.

Apollo Hospitals Reports Strong Q1 Performance and Growth - 16 Aug, 2024

Apollo Hospitals Enterprise Ltd reported strong Q1 FY25 results, with an 83% increase in net profit and 15% revenue growth. Analysts remain bullish, raising price targets and projecting continued growth across all segments. The company also announced a final dividend of Rs 10.

Apollo Hospitals Reports Strong Q1 Growth and Expansion Plans - 14 Aug, 2024

Apollo Hospitals Enterprise Ltd reported an 83% increase in Q1 net profit to ₹305 crore, with revenue rising 15.1% to ₹5,085.60 crore. The company plans to add 1,500 beds and aims for 30% revenue growth over three years. Shares surged 4% following the positive earnings announcement.